首页> 美国卫生研究院文献>Thoracic Cancer >Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma

【2h】

Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma

机译：尼妥珠单抗联合化学疗法作为晚期肺鳞癌的一线治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThis study was conducted to evaluate the efficacy and safety of nimotuzumab combined with chemotherapy as first‐line therapy in advanced lung squamous cell carcinoma (LSCC), and to explore predictive biomarkers of the efficacy of nimotuzumab.

机译：背景本研究旨在评估尼莫妥珠单抗联合化疗作为一线治疗晚期肺鳞状细胞癌（LSCC）的疗效和安全性，并探讨尼莫妥单抗疗效的预测生物标志物。

著录项

期刊名称 Thoracic Cancer
作者
Xiaoyan Si; Shafei Wu; Hanping Wang; Xiaotong Zhang; Mengzhao Wang; Xuan Zeng; Li Zhang;
展开▼
作者单位

展开▼
年(卷),期 2018(9),8
年度 2018
页码 1056–1061
总页数 6
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Chemotherapy lung squamous cell carcinoma nimotuzumab;

机译：化学疗法;肺鳞状细胞癌;尼莫妥单抗;

相似文献

外文文献
中文文献
专利

1. Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma [J] . Xiaoyan Si, Shafei Wu, Hanping Wang, Thoracic cancer. . 2018,第8期

机译：尼妥珠单抗联合化学疗法作为晚期肺鳞癌的一线治疗
2. PUB125 Clinical Observation of Nimotuzumab Combined with Chemotherapy as First Line Therapy for Advanced Lung Squamous Cell Carcinoma [J] . Xiaoyan Si, Xiaotong Zhang, Hanping Wang, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：PUB125 Nimotuzumab与化疗结合化疗的临床观察作为晚期肺鳞状细胞癌的第一线疗法
3. PUB125 Clinical Observation of Nimotuzumab Combined with Chemotherapy as First Line Therapy for Advanced Lung Squamous Cell Carcinoma [J] . Xiaoyan Si, Xiaotong Zhang, Hanping Wang, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：PUB125 Nimotuzumab与化疗结合化疗的临床观察作为晚期肺鳞状细胞癌的第一线疗法
4. Interstitial laser and chemotherapy combined for treatment of human squamous cell carcinoma [C] . Romaine E. Saxton, UCLA School of Medicine, Los Angeles, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems VII . 1997

机译：间质激光和化学疗法联合治疗人鳞状细胞癌
5. Gene expression analysis of human non -small cell lung cancer subtypes, adenocarcinoma and squamous cell carcinoma, and mouse lung epithelial cell lines: Implications in lung tumorigenesis [D] . Silvers, Amy Lynn. 2002

机译：人类非小细胞肺癌亚型，腺癌和鳞状细胞癌以及小鼠肺上皮细胞系的基因表达分析：在肺肿瘤发生中的意义
6. Phase II Study of a Bi-Weekly Chemotherapy Regimen of Combined Liposomal Paclitaxel and Nedaplatin for the Treatment of Advanced Squamous Cell Lung Cancer [O] . Wei-Ze Lv, Zhong Lin, Si-Yang Wang, 2019

机译：脂质体紫杉醇和奈达铂联合双周化疗方案治疗晚期鳞状细胞癌的第二阶段研究
7. Nimotuzumab combined with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma [O] . Xiaoyan Si, Shafei Wu, Hanping Wang, 2018

机译：Nimotuzumab结合化疗作为晚期肺鳞状细胞癌的一线治疗

Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅